KLRAKailera Therapeutics, Inc.

• 2026-06-11 · Renaud Ronald C JR (CEO & President) · OTHER
• 2026-04-22 · RTW INVESTMENTS, LP (10% Owner) · OTHER
• 2026-04-22 · Jiangsu Hengrui Pharmaceuticals Co., Ltd. (10% Owner) · OTHER
• 2026-04-22 · RTW INVESTMENTS, LP (10% Owner) · BUY

• Kailera Therapeutics presents Phase 1 data for ribupatide injection
• Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection
• Kailera Therapeutics: Hold Due To Need For Progress On Weight Loss Differentiation
• Kailera Therapeutics: An Outside Biotech Bet For The Next GLP-1 Obesity Drug Approval
• Kailera Therapeutics to Participate in September Investor Conferences